Skip to main content

Agios Pharmaceuticals, Inc.

AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001439222

In the last 90 days, Agios Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 238 institutions reported holding it in 13F filings for Q2 2026, worth $2.45B in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Agios Pharmaceuticals, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of AGIO: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders2383234−1
Shares61.3M5.59M63.1M+7.41M (+13.3%)
Value$1.67B$152.3M$2.12B+$605.4M (+40.0%)

3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (36)

Institutions that held Agios Pharmaceuticals, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to AGIO in Q1 2026
InstitutionSharesValue% of portfolio
Vanguard Capital Management LLC2,632,316$89.1M0.00%
Vanguard Portfolio Management LLC2,611,035$88.3M0.00%
Vanguard Fiduciary Trust Co382,021$12.9M0.00%
Arrowstreet Capital, Limited Partnership250,461$8.47M0.00%
Schonfeld Strategic Advisors LLC200,061$6.77M0.06%
Eversept Partners, LP200,000$6.77M0.45%
Man Group plc144,297$4.88M0.01%
Essex Investment Management Co LLC103,177$3.49M0.55%
Tang Capital Management LLC100,000$3.38M0.17%
Vanguard Asset Management, Ltd58,648$1.98M0.00%
Gsa Capital Partners LLP36,472$1.23M0.08%
Martingale Asset Management L P35,814$1.21M0.03%
Legato Capital Management LLC32,373$1.10M0.10%
Vanguard Global Advisers, LLC23,352$790.0K0.00%
Virtu Financial LLC21,392$724.0K0.03%
CenterBook Partners LP17,445$590.2K0.03%
PSP Research LLC15,000$507.4K0.36%
Vanguard Investments Australia, Ltd.13,537$458.0K0.00%
E Fund Management Co., Ltd.12,915$436.9K0.01%
Voleon Capital Management LP9,679$327.4K0.01%
Ground Swell Capital, LLC8,347$282.4K0.56%
Franklin Resources Inc8,287$280.3K0.00%
PDT Partners, LLC7,500$253.7K0.02%
Savvy Advisors, Inc.6,794$229.8K0.01%
Magnetar Financial LLC5,936$200.8K0.00%
Acadian Asset Management LLC5,859$196.0K0.00%
Bayforest Capital Ltd2,815$95.2K0.11%
Kemnay Advisory Services Inc.477$16.1K0.00%
Clear Street Markets LLC408$13.8K0.01%
Advisory Services Network, LLC350$11.8K0.00%
Fifth Third Bancorp209$7.09K0.00%
Optiver Holding B.V.108$3.65K0.00%
JPL Wealth Management, LLC70$2.37K0.00%
Larson Financial Group LLC66$2.23K0.00%
MAI Capital Management37$1.25K0.00%
True Wealth Design, LLC12$4060.00%

Sold out (37)

Institutions that held Agios Pharmaceuticals, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Not filed for Q1 2026 yet (3)

Institutions that held Agios Pharmaceuticals, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AGIO in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Vanguard Group Inc5,594,353$152.3M
Comerica Bank209$5.70K
Global Retirement Partners, LLC11$299